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Introduction
White adipose tissue plays a pivotal role in the regulation of energy balance by storing free fatty acids in fat cells in the form of triglycerides and releasing them through triglyceride hydrolysis (lipolysis). The regulation of lipolysis is well characterized in adult humans; only three hormone systems acting on distinct pathways are important [1] . Thus, catecholamines stimulate lipolysis through cyclic AMP whilst natriuretic peptides stimulate it through the cyclic GMP pathway. Insulin inhibits lipolysis by acting through the phosphatidylinositol 3-kinase (P13K) pathway which targets phosphodiesterase thereby converging with catecholamines on regulating cyclic AMP levels. Insulin stimulates lipid synthesis in fat cells by increasing the conversion of glucose to triglycerides (lipogenesis) through P13K [2] . In addition, human adipose tissue displays important spontaneous (basal) lipolytic and lipogenic activities [3] . A central intrinsic regulator of lipolysis and lipogenesis is fat cell size. Large cells are much more lipolytic and less lipogenic than small ones [3, 4] .
As reviewed, it is well established that there is a strong pathophysiological link between adipose tissue, insulin resistance and type 2 diabetes [5, 6] . This is at least in part mediated by fat cell lipolysis and lipogenesis. Adipocyte lipolysis is increased and lipogenesis is decreased in insulin resistant obese individuals or type 2 diabetic subjects. In addition, independently of body weight status, large fat cells are linked to increased risk of developing type 2 diabetes [7, 8] . The described alterations will elevate circulating free fatty acid levels which, in turn, may induce insulin resistance and inhibit insulin release as reviewed [9] .
Unlike conditions such as obesity/insulin resistance/type 2 diabetes, and with the exception of some studies of dyslipidemia, very little is known about the association between fat cell size and adipocyte lipid metabolism with cardiovascular disease [10] [11] [12] [13] [14] [15] . Thus, it is currently unknown whether subjects with an adverse cardiovascular risk profile have alterations in fat cell lipid metabolism.
In this study, we examined whether there is a relationship between cardiovascular risk factors, defined according to the well-established ATP III score [16] , and fat cell lipid metabolism using a very large cohort with marked interindividual variations in body mass index (BMI). Fat cell size, as well as the basal (spontaneous) and hormonestimulated lipolytic/lipogenic properties were determined. Analyses were corrected for the influence of major factors impacting on fat cell size and function (age, sex and body weight status).
Materials and methods

Subjects
All participants lived in the area of Stockholm, Sweden at the moment of investigation. They have, since 1986, been continuously recruited by local advertisement for studies of human adipose tissue function. A recent investigation on genetic polymorphisms has been published on this cohort [17] . Subjects with diabetes treated with insulin, glitazones or glucagon likepeptide analogues were excluded as well as individuals with severe chronic diseases. The cohort consisted of 304 men and 775 women. A total of 159 subjects were treated for type 2 diabetes, hypertension or hyperlipidaemia. The study was explained in detail to each person and informed written consent was obtained. It was approved by the regional board of ethics.
Procedures
The subjects came to the laboratory in the morning after an overnight fast. Height, weight and circumferences of waist and hip were determined. Blood pressure was measured exactly as described [18] . Subsequently, a venous blood sample was obtained for determination of triglycerides, HDL cholesterol and glucose by the hospital's routine clinical chemistry laboratory and fatty acids were determined as described [19] . Obtained measures were used to classify the subjects according to ATPIII scores for the metabolic syndrome ranging from 0 to 5 [16, 20] . A score of 1 point was given for each of the following traits:
(men/women), waist ≥102/88 cm (men/women) and blood pressure ≥130 (systolic) or ≥85 (diastolic) mm Hg. According to this definition, scores ≥3 define the metabolic syndrome and thereby high cardiovascular risk. Subjects on pharmacological treatment against diabetes, hypertension or hyperlipidaemia scored for these conditions regardless if the values of the respective clinical measures were normal at the time of investigation. Finally, an abdominal subcutaneous fat biopsy was obtained by needle aspiration under local anaesthesia as described [21] . Adipose tissue was subjected to collagenase isolation of fat cells, and diluted fat cell suspensions (15-10 000 cells mL
À1
) were incubated for 2 h at 37°C in an albumin and glucose containing buffer (pH 7.4) as described [22] . The incubations were conducted in the absence (basal) or presence of increasing concentrations of the natural hormones noradrenaline, atrial natriuretic peptide (ANP) or insulin. In addition, isoprenaline -a synthetic catecholamine which acts as a nonselective beta-adrenoceptor agonist-was used. Basal lipolysis is prominent in human WAT [23] and not an artificial measure. For example, the basal rate of glycerol release is constant for several hours in human subcutaneous WAT pieces incubated ex vivo [23] . Regarding pro-lipolytic hormones, noradrenaline was chosen instead of adrenaline because it more prominently reflects overall sympathetic neurone activity [24] . In addition, noradrenaline is the major lipolysis regulator upon physical activity whereas adrenalin is above all activated by cold exposure and mental stress [24] , stressors which we regarded to be less relevant in the present analysis. It has previously been demonstrated that hormone-stimulated lipolysis in isolated fat cells correlates with the same measures in situ (using microdialysis) [25] and in vivo [26] . On the other hand, basal lipolysis in vitro and in vivo does not correlate to the same degree [27] . In the insulin experiments, the medium was also supplemented with 1 mU L À1 of adenosine deaminase to remove traces of adenosine which through its antilipolytic effect may influence the action of insulin [28] and with 1 mmol L À1 of the phosphodiesterase sensitive cyclic AMP analogue 8-bromo cyclic AMP (8bcAMP) because insulin inhibits lipolysis through cyclic AMP hydrolysis [29] . At the end of the incubation, an aliquot of the medium was removed for determination of glycerol [30] which was used as a lipolysis index expressed per fat cell number. It should be noted that whilst both glycerol and fatty acids are end products of triglyceride lipolysis, fatty acids released through lipolysis can be re-esterified by fat cells. This contrasts with glycerol which is insignificantly re-utilized and therefore a better measure of lipolysis. In separate experiments, lipogenesis was determined exactly as described [22, 31] . In brief, fat cell suspensions (2% vol/vol) were incubated in the absence (basal) or presence of increasing concentrations of insulin (40 mg mL À1 ) and glucose (1 lmol L
) containing buffer (pH 7,4) for 2 h at 37°C in the presence of 3 H-glucose (5 9 10 5 dpm mL À1 ) and varying concentrations of human insulin (0-70 nmol L À1 ). Incubations were stopped by putting the vials on ice. Lipogenesis was determined as the incorporation of radiolabeled glucose into adipocyte lipids (mainly into the glycerol backbone of triglycerides) and expressed per fat cell number. Note that the protocol uses very low glucose concentrations (lmol L À1 ). At these levels, the rate limiting step is glucose uptake [31] . For both lipolysis and lipogenesis, results were expressed at the maximum effective hormone concentrations (responsiveness) and as pD2, which is the negative 10 log molar value of the half maximum effective concentration and determined by logarithmic linearization of the concentrationresponse curves. According to classical drugresponse theories, responsiveness represents the action of the hormones at steps distal from receptors whereas pD2 represents the action at or a near the receptor level, that is hormone sensitivity [32] . Finally, mean fat cell size and weight were determined exactly as described [33] . In brief, the diameters of 100 cells were measured and used in well-established formulas to obtain mean size and weight. The validity of the method has been discussed in detail [33] . The number of fat cells incubated was determined by dividing lipid weight of that incubated sample by mean fat cell weight.
There is no consensus on how to present lipolysis/ lipogenesis data for fat cells. As this was a clinical investigation and fat cell size is an established metabolic risk factor, we used expression per number of fat cell which enabled us to directly compare metabolic effects with fat cell size. Because limited amounts of adipose tissue could be obtained by needle biopsy, it was usually not possible to make a complete adipose investigation in all subjects although fat cell size was always measured. Lipolysis measures were less tissueconsuming and could be obtained in 1015 subjects whilst lipogenesis was measured in 472 subjects.
Statistics
Values are mean AE SD in text and tables and mean AE standard error of mean (SE) in figures. They were compared by analysis of covariance (ANCOVA), Fisher's exact test and logistic or multiple regression.
Results
Clinical data are presented in Table 1 . To increase the number of subjects in the highest bin, subjects with ATPIII scores 4 and 5 were combined. As expected, all clinical variables used for ATPIII classification were gradually worse with increasing score. The same was true for BMI and age, but there was no difference in gender distribution between scores. Plasma free fatty acid levels were also positively correlated with ATPIII and were about 50% higher amongst subjects in the top score as compared to those in the lowest. Furthermore, there was a gradual increase in fat cell size with increasing ATPIII. All results remained highly significant (P < 0.0001) when corrected for age, BMI and gender (combined) in the ANCOVA.
Basal lipolysis and lipolysis stimulated by noradrenaline or ANP are depicted in Fig. 1 . There was a gradual increase in basal lipolysis (Fig. 1a) and noradrenaline responsiveness (Fig. 1b) with increasing ATPIII whilst noradrenaline sensitivity was not influenced (Fig. 1c) . For ANP-induced lipolysis neither responsiveness (Fig. 1d) nor pD2  (Fig. 1e) differed between groups.
The action of insulin is depicted in Fig. 2 . Lipolysis induced with 8bcAMP alone (Fig. 2a) or in the presence of a maximum effective concentration of insulin (Fig. 2b) increased with increasing ATP score. Basal (Fig 2d) and insulin-stimulated lipogenesis (reflecting primarily glucose uptake) (Fig. 2e) decreased gradually with increasing Fat cells and cardiovascular risk / M. Ryd en and P. Arner ATPIII score and the same was observed for pD2 for both the antilipolytic (Fig. 2c) and lipogenic  (Fig. 2f) effects of insulin. It is worth mentioning that the fact that noradrenaline (Fig. 1b) and  8bcAMP (Fig. 2a) responsiveness displayed similar associations with ATPIII score implies that the antilipolytic a2A-adrenoceptor does not play a role in the observed correlations. This conclusion is further supported by the fact that similar relationships were observed when lipolysis was stimulated with a maximum effective concentration of isoprenaline, a pure b-adrenoceptor agonist (graph not shown).
We next investigated if fat cell parameters contributed to ATPIII score independently of gender, BMI or sex. This was done using logistic regression and dividing the subjects into low (score 0-2) and high (score 3-5) cardiovascular risk ( Table 2 ). All statistically significant results presented in the figures except for 8bcAMP alone were independently related to risk score.
To determine which set of adipocyte parameters that fitted best to high (3-5) or low ATPIII score, various models were tested in logistic regression. The best model included insulin-stimulated lipogenesis, pD2 for the antilipolytic effect of insulin and basal lipolysis (Table 3) . Adjusted r 2 for the whole model was 0.19; each factor contributed significantly to the model although insulin-stimulated lipogenesis and insulin sensitivity were the strongest predictors. We also considered determining how the different adipocyte measures were related to specific risk factors in the ATPIII score. Unfortunately, the contribution of individual parameters was unevenly distributed. For instance, amongst the 261 subjects with an ATPIII score of 1, 158 scored for waist whilst only a minority scored for other risk factors (21 for hypertension, nine for glucose, 47 for HDL-C and 26 for TG). Similarly, amongst the 284 subjects with a risk score of 2, 138 scored for waist and HDL-C whilst the remaining eight groups were very small ranging from three to 46 subjects. This precluded a more in-depth analysis. Nevertheless, amongst subjects with a risk score of 3 we identified 39 subjects with 1 point each for waist, hypertension and glucose and 87 with one score each for waist, HDL-C and TGs. In these two groups, discordant in glucose/hypertension versus dyslipidemia, basal lipolysis, antilipolytic insulin sensitivity and insulin-mediated lipogenesis were not significantly different (values not shown). 
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Finally, to examine the influence of fat cell size on fat cell metabolism we performed a multiple regression analysis with fat cell size, gender, BMI and age put together as independent regressors for different measures of lipid metabolism (Table 4 ).
In this model fat cell size correlated significantly with all functional fat cell measures significantly related to ATPIII score in Figs 1 and 2.
About 15% of the subjects were treated for type 2 diabetes, hypertension or hyperlipidaemia. However, the results were not influenced in any important way if these individuals were excluded in the analyses.
Discussion
This study was undertaken to determine the relationship between functional parameters of subcutaneous adipocyte lipid metabolism and cardiovascular risk A logistic regression model of ATPIII score versus age, sex, BMI and different fat cell lipid metabolism regressors was investigated. The scores were divided into low (0-2) and high (3-5) risk. The regressors were put together and analysed versus APTIII using logistic regression. Adjusted r 2 for the whole model was 0.19 (P < 0.0001). factors. A very large cohort of men and women was examined and the subjects were classified according to ATPIII score, a well-established index of cardiovascular risk [16] . Our findings suggest that multiple disturbances in fat cell lipid handling contribute to variations in risk scores independently of confounding factors known to influence fat cell size and function (i.e. age, sex and BMI).
For hormone-stimulated effects, this includes the action of catecholamines and insulin on lipolysis as well as the action of insulin on lipogenesis. In contrast, ANP-mediated regulation of lipolysis does not seem to play a role. This is in line with recent data suggesting that ANP-and catecholaminestimulated lipolysis are differentially altered in obesity [34] and suggests that the link between risk score and fat cell metabolism is specific for certain signalling pathways. These pathways involve cyclic AMP and P13K but not cyclic GMP. In addition, the spontaneous (basal) lipolytic and lipogenic activities also contribute to the variations in ATP III risk score.
Because of the limited amounts of adipose tissue that could be obtained in this clinical setting, it was impossible to make detailed mechanistic studies related to the findings. However, the pharmacological nature of the study allows some conclusions. For catecholamines, the associations with responsiveness but not with hormone sensitivity (pD2) suggest that distal rather than receptor-near signalling disturbances are involved. For insulin, on the other hand, multiple events in hormone signalling both near and distal to the receptor must be involved. Importantly, these relationships were observed in the physiological concentration range for both insulin and noradrenaline as shown by the pD2 values (corresponding to 10 À12 -10 À15 mol L
À1
and 10 À8 -10 À9 mol L À1 for insulin and noradrenaline, respectively). A likely common regulatory factor linking fat cell lipid metabolism to high ATPIII score is enlarged fat cells. As mentioned before, it is well established that large fat cells have increased lipolysis and decreased lipogenesis. Indeed all metabolic measures that were linked to ATPIII correlated also significantly to fat cell size independently of important confounding factors such as BMI, gender and age.
Are the present findings clinically relevant? We believe so. The levels of fatty acids were markedly increased at the highest ATPIII score. All observed fat cell lipid measures linked to ATPIII may result in increasing circulating concentrations of free fatty acids. When elevated, these lipids may cause insulin resistance, dyslipidemia, glucose intolerance, hypertension and ultimately cardiovascular disease as discussed and/or demonstrated previously [5, 6, 9, [35] [36] [37] [38] . When different functional aspects of adipocyte lipid handling are compared, it appears that insulin-stimulated lipogenesis, sensitivity to the antilipolytic effect of insulin and basal lipolysis activity are the most important. Together they explain about 20% of the variation in ATPIII score. This constitutes a significant influence, bearing in mind the numerous other factors that may impact on the development of a high ATP III score (life style, genetics, smoking habits, inflammation and so on).
There are some caveats with the present study. We investigated more women than men, reflecting the relative difficulties in recruiting the latter to this type of study. However, the material was sufficiently large to exclude important gender influence. We did not investigate visceral adipose tissue which is also linked to cardiovascular risk as discussed [39, 40] . Unfortunately, this depot can only be studied in connection with general surgery which precludes this type of large scale studies. Finally, although the present cohort was very large it was not sufficient to allow an in-depth subgroup analysis of the contribution of adipocyte lipolysis measures to individual risk factors in the ATPIII score.
In summary, multiple aspects of lipid handling in subcutaneous fat cell are linked to increased cardiovascular risk independently of age, sex and BMI. Dysfunction in these measures may explain the elevated circulating free fatty acid levels observed in persons with a high cardiovascular risk score. A common denominator linking altered fat cell lipid metabolism to high cardiovascular risk is enlarged fat cells.
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